🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT04393649
Active, not recruiting Observational

First Level Socio-geriatric Evaluation: ESOGER Databank

NCT04393649 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2020-04-20
Last updated
2024-02-23

Condition(s) studied

COVIDSocial IsolationAnxietyFrailty

Investigational drug(s) / intervention(s)

ESOGER

ESOGER: Questionnaire

Study summary

Coronavirus disease 2019 (COVID-19) is an infectious disease. Physical distancing is one of the most effective ways to reduce the spread of COVID-19, but this key prevention intervention may have adverse consequences on older adults living at home. Screening older adults living at home and at risk for adverse consequences of physical and social distancing is, therefore, a priority in order to prevent their occurrence. ESOGER ("Evaluation Social et GERiatrique") is a clinical tool designed to: 1) screen the risk-levels for adverse consequences related to COVID-19 physical distancing and 2) to continue appropriate preventive interventions in older adults living at home including frail older patients and older community dwellers. Experience cumulated during the past two weeks revealed that ESOGER could be improved, in order to be more effective and efficient for the prevention of adverse consequences related to COVID-19 physical distancing. This improvement is based on two key components: 1) Comments of Montreal ESOGER users and 2) Analysis of data. Because at this time no information is saved and stored, there is a need to save and store ESOGER information and create the ESOGER databank.

Eligibility

Sex
ALL
Min age
70 Years
Max age
—
Healthy volunteers
No
The inclusion criteria are: 1. Older (i.e., 70-years-old and over) adults OR caregiver living at home with an adult answering to inclusion criteria 2. Living and staying at home because of physical and social distancing 3. Understanding and writing the different languages of the recruitment centre (i.e., French, English, Chinese.) 4. Agree to participate in the study The exclusion criteria are: 1. A concomitant participation to another medical trial 2. Living in semi-autonomous residence or CHSLD

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Jewish General Hospital Montreal Quebec

More Jewish General Hospital trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04393649 on ClinicalTrials.gov ↗ ← All trials in Canada